Quantitative In Vivo Proteomics of Metformin Response in Liver Reveals AMPK-Dependent and -Independent Signaling Networks
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 29 (10) , 3331-3348.e7
Abstract
No abstract availableKeywords
Funding Information
- Waitt Foundation
- James B. Pendleton Charitable Trust
- NOMIS Stiftung
- American Cancer Society (122123-PF-12-029-01-TBE)
- National Institutes of Health (1DP2GM105455-01, P01-CA120964, P41-GM103533, R01-DK080425, R01-MH068770, R35 CA197588, R35-CA220538)
This publication has 105 references indexed in Scilit:
- LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug PhenforminCancer Cell, 2013
- Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and AutophagyCell, 2013
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?Cell, 2012
- Chemical Genetic Screen for AMPKα2 Substrates Uncovers a Network of Proteins Involved in MitosisMolecular Cell, 2011
- Enrichment techniques employed in phosphoproteomicsAmino Acids, 2011
- Evolutionary origins of STIM1 and STIM2 within ancient Ca2+ signaling systemsTrends in Cell Biology, 2011
- A Tissue-Specific Atlas of Mouse Protein Phosphorylation and ExpressionCell, 2010
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008